Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) - Total Liabilities

Latest as of June 2025: $4.43 Million USD

Based on the latest financial reports, Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (HKPD) has total liabilities worth $4.43 Million USD as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore HKPD shareholders equity momentum to track the company's year-over-year net asset growth rate.

Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares - Total Liabilities Trend (2023–2025)

This chart illustrates how Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares's total liabilities have evolved over time, based on quarterly financial data. See Hong Kong Pharma Digital Technology Hold free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.

Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares Competitors by Total Liabilities

The table below lists competitors of Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares ranked by their total liabilities.

Company Country Total Liabilities
Moolec Science SA Ordinary Shares
NASDAQ:MLEC
USA $28.58 Million
Samchai Steel Industries Public Company Limited
BK:SAM
Thailand ฿2.41 Billion
Tianci International, Inc. Common Stock
NASDAQ:CIIT
USA $104.04K
Anagenics Ltd
AU:AN1
Australia AU$1.82 Million
Hansa Investment Company Ltd
LSE:HANA
UK GBX513.00K
Astrotech Corp
NASDAQ:ASTC
USA $4.18 Million
IMPRENDIROMA S.P.A.
F:Y37
Germany €22.61 Million
Tantech Holdings Ltd
NASDAQ:TANH
USA $27.89 Million

Liability Composition Analysis (2023–2025)

This chart breaks down Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market value of Hong Kong Pharma Digital Technology Hold.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.99 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.89 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.47 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares (2023–2025)

The table below shows the annual total liabilities of Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares from 2023 to 2025.

Year Total Liabilities Change
2025-03-31 $4.43 Million +0.32%
2024-03-31 $4.41 Million +56.43%
2023-03-31 $2.82 Million --

About Hong Kong Pharma Digital Technology Holdings Limited Ordinary shares

NASDAQ:HKPD USA Pharmaceutical Retailers
Market Cap
$4.87 Million
Market Cap Rank
#28592 Global
#5782 in USA
Share Price
$0.44
Change (1 day)
+8.61%
52-Week Range
$0.33 - $1.74
All Time High
$2.80
About

Hong Kong Pharma Digital Technology Holdings Limited, an investment holding company, engages in the over the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers custom clearance, drugs enlisting, warehouse, and other logistics services. The comp… Read more